EGFL7 and systemic sclerosis: Serum EGFL7 levels were significantly decreased in SSc patients with late NVC pattern compared with healthy controls (P = 0.006), whereas although decreased, no significant difference in EGFL7 levels could be found between SSc patients with early or active NVC patterns and controls (Figure 1B).